EUVIMEDEUVIMED entdecken
Crossref

Impact of repeated endobiliary radiofrequency ablation on survival in unresectable perihilar cholangiocarcinoma

Yoonchan Lee iD, Tae Jun Song, Sehee Kim, Sung Hyun Cho iD, Gunn Huh, Dongwook Oh iD, Dong-Wan Seo

Endoscopy · 29.10.2026

DOI: 10.1055/a-2971-5831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, online erschienen am 29.10.2026. Verfasst von Yoonchan Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Asan Medical Center, Department of Gastroenterology, Korea (the Republic of), Seoul. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence regarding the survival benefit of endobiliary radiofrequency ablation (RFA) in perihilar cholangiocarcinoma (CCA) remains limited. We evaluated the association between endobiliary RFA and overall survival in unresectable perihilar CCA, with a focus on the timing of exposure. This retrospective cohort study included 475 patients with unresectable perihilar CCA treated with endoscopic biliary drainage between 2015 and 2025 (90 with a single RFA session, 50 with two or more sessions). RFA was modeled as a time-dependent cumulative count (0, 1, or ≥2 sessions), with landmark analyses of subsequent 6-month mortality at baseline and 3, 6, 9, and 12 months. Sensitivity analyses adjusted for stent type and calendar year. RFA within 7 days of drainage was associated with lower 6-month mortality (adjusted hazard ratio [aHR] 0.34, 95%CI 0.16–0.70; P = 0.004). At the 3-month landmark, two or more sessions were associated with lower mortality (aHR 0.10, P = 0.02); no association was seen at later landmarks. These estimates were unchanged after adjustment for stent type and calendar year. Over the entire follow-up, two or more sessions were associated with lower mortality (aHR 0.59, P = 0.007), but this association was attenuated after adjustment for calendar year (aHR 0.77, P = 0.21). Recurrent biliary obstruction was more frequent after RFA (37.9% vs. 22.1%; P < 0.001), with the excess confined to nontumor causes. Endobiliary RFA was associated with improved survival in unresectable perihilar CCA, with the benefit concentrated in the first 3 months after biliary drainage, at the cost of more frequent nontumor-related biliary obstruction.

Autor:innen und Institutionen

  • Asan Medical Center, Department of Gastroenterology, Korea (the Republic of), Seoul.
  • Asan Medical Center, Department of Clinical Epidemiology and Biostatistics, Korea (the Republic of), Seoul.
  • Chulalongkorn University, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Thailand, Bangkok.

ORCID-Profile: Yoonchan Lee, Sung Hyun Cho, Dongwook Oh

Zitieren

APA

Lee, Y., Song, T. J., Kim, S., Cho, S. H., Huh, G., Oh, D., & Seo, D. W. (2026). Impact of repeated endobiliary radiofrequency ablation on survival in unresectable perihilar cholangiocarcinoma. Endoscopy. https://doi.org/10.1055/a-2971-5831

Vancouver

Lee Y, Song TJ, Kim S, Cho SH, Huh G, Oh D, et al. Impact of repeated endobiliary radiofrequency ablation on survival in unresectable perihilar cholangiocarcinoma. Endoscopy. 2026. doi:10.1055/a-2971-5831

BibTeX
@article{Lee2026,
  author = {Lee, Yoonchan and Song, Tae Jun and Kim, Sehee and Cho, Sung Hyun and Huh, Gunn and Oh, Dongwook and Seo, Dong-Wan},
  title = {Impact of repeated endobiliary radiofrequency ablation on survival in unresectable perihilar cholangiocarcinoma},
  journal = {Endoscopy},
  year = {2026},
  doi = {10.1055/a-2971-5831}
}
Kostenlos starten →